Connect with us


PSG-W vs KHA-W Live Score Dream11 Prediction Womens Champions League Paris Saint-Germain Women vs Kharkiv Women



Are you looking for an extraordinary and exciting football match? we want to tell you about a match which is square between the two most brilliant teams. Here is an upcoming match that will be square off between PSG-W vs KHA-W. As per the details the match will be played on October 13, 2021. Complete detail is here and you will know about every related keypoint like match prediction, dream11 probable lineups and live score as well.

PSG-W vs KHA-W Live Score

Match: PSG-W vs KHA-W
Date: October 13, 2021
Time: 22:15
Venue:  Stade Georges Lefevre, Paris, France

PSG-W vs KHA-W Live Score

In the recent matches, both the teams have played such numbers of matches. As per the details, the team PSG-W has won all five matches in the last five matches played. There is a huge chance that it will maintain the same level of performance in the upcoming match also.

No doubt they will maintain the same level of gameplay and win the upcoming football match also. While discussing another team then we want to tell you that team KHA-W also played such massive and impressive gameplay where they won 4 matches continuously and unfortunately lost 1 match also.

This is a very interesting match and you can watch the live stream of this match on your tv. There are many matches that will be played in the upcoming weeks also. Stay connected with us for more.

Paris Saint-Germain Women:1.Charlotte Voll, 2.Sandy Baltimore, 3.Ashley Lawrence, 4.Paulina Dudek, 5.Jade Le guilly, 6.Launa, 7.Sara Dabritz, 8.Kheira Hamraoui, 9.Lea Khelifi, 10.Ramona Bachmann, 11.Marie Antoinette Katoto

Kharkiv Women: 1.Gamze Yaman, 2.Kristine Aleksanyan, 3.Anastasiia Voronina, 4.Lyubov Shmatko, 5.Anna Petryk, 6.Nadiia Khavanska, 7.Olha Boychenko, 8.Yuliia Shevchuk, 9.Daryna Apanaschenko, 10.Birgul Sadikoglu, 11.Olha Ovdiychuk

As per the available detail in this upcoming match, you will see the team PSG-W will win the match and defeat the opponent team KHA-W. They will do a massive score as we are predicting after watching the recent gameplay.

You can watch the match live stream on the regular broadcaster platform. However, you will see a live score update in this article as well. For further news, stay get in touch with us.

Source link


SARS-CoV-2 Shedding in Semen and Oligozoospermia of Patient with Severe Coronavirus Disease 11 Weeks after Infection – The Maravi Post




Disclaimer: Early release articles are not considered as final versions. Any changes will be reflected in the online version in the month the article is officially released.

Author affiliations: Columbia Mailman School of Public Health, New York, New York, USA (L.J. Purpura); Columbia University Irving Medical Center, New York (L.J. Purpura, J. Alukal, A.M. Chong, L. Liu, A. Cantos, J. Shah, N. Medrano, J.Y. Chang, M. Tsuji, H. Mohri, A.C. Uhlemann, D. Ho, M.T. Yin)

As of July 2021, >180 million persons worldwide were infected by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and remain in the convalescent phase (1). Long-term implications for male fertility and potential sexual transmission remain uncertain. However, other emerging pathogens, such as Ebola and Zika viruses, have been shown to undergo sexual transmission (2,3).

Angiotensin-converting enzyme-2 receptors, abundant in the testis (4), are binding sites for SARS-CoV-2, and autopsy reports have demonstrated viral invasion of the testis (5). However, detection of SARS-CoV-2 RNA in semen was not reported from 6 cohort studies that included 213 men (6), although detection has been reported in 2 studies during the acute phase (7,8) and in 1 study during early convalescence (9). We present findings of semen analysis from a prospective coronavirus disease (COVID-19) cohort study.

The Study

A 34-year-old man, who had a history of childhood asthma, was hospitalized for severe coronavirus disease (COVID-19) pneumonia during March 2020. At admission, he had symptoms for 1 week and was positive for SARS-CoV-2 RNA by nasopharyngeal swab specimen reverse transcription PCR (RT-PCR). Chest radiograph showed bilateral interstitial opacities. He was given supplementary oxygen by nasal cannula and completed a 5-day course of hydroxychloroquine but was also given mechanical ventilation on day 10 for respiratory decompensation. His hospital course was complicated by renal failure requiring continuous venovenous hemofiltration. He was eventually extubated on illness day 15 but remained admitted until day 27, when he no longer required supplemental oxygen. Despite his respiratory recovery, he required outpatient dialysis until day 51. At the time of study enrollment (day 72), he had returned to his previous state of health.

Participants were recruited for this prospective cohort study from inpatient and outpatient settings in New York, New York, beginning in March 2020. The study was approved by the institutional review board at Columbia University Irving Medical Center and is registered at (NCT04448145). Eligible participants had laboratory confirmation of COVID-19 based on SARS-CoV-2 RT-PCR or serologic testing. Participants completed surveys describing their demographics, underlying conditions, and COVID-19 clinical course. Clinical samples collected at each visit included plasma, peripheral blood mononuclear cells, nasopharyngeal swab specimens, saliva samples, stool/rectal swab specimens, and semen.

We collected and assessed semen per World Health Organization guidelines (10). We instructed participants to clean their hands without spermotoxic lubricants before providing a sample into a sterile container. Samples were frozen after collection. Sperm count was reported in millions per milliliter, and sperm mho provided semen specimens were Hispanic, 2 Black, and 3 Caucasian; 2 had a previous diagnoses of HIV infection, and 2 had body mass index >30 kg/mg2. One participant had had a successful vasectomy and was included in the study to evaluate viral carriage in nontestes accessory organs, such as the prostate gland.

Of the 107 patients enrolled in the cohort study, 7 provided semen specimens (Table 1; Appendix). The mean age of participants was 38.7 (range 32–56) years. Two of the 7 who provided semen specimens were Hispanic, 2 Black, and 3 Caucasian; 2 had a previous diagnoses of HIV infection, and 2 had body mass index >30 kg/mg2. One participant had had a successful vasectomy and was included in the study to evaluate viral carriage in nontestes accessory organs, such as the prostate gland.

A total of 17 semen specimens were collected from 7 participants (Table 1) and underwent quantitative RT-PCR (qRT-PCR) testing and semen analysis. We assessed cycle threshold (Ct) values by using the ZymoBIOMICS DNA/RNA Extraction Kit (Zymoresearch,, the Taqman 4× One-Step Master Mix (Zymoresearch), and SARS-CoV-2 IDT primer/probe sets (Integrated DNA Technologies, One sample obtained from participant 1 on day 81 from symptom onset was qRT-PCR positive and had a Ct value of 34.79. Virus isolation was unsuccessful (Appendix). Subsequent semen samples from the participant at days 101 and 169 were negative, as were his saliva, stool, and plasma samples (Table 2). All semen samples from the other 6 men were negative by qRT-PCR.

Participant 1 had severe oligozoospermia and a sperm concentration of <1 million/mL on day 81, followed by a gradual recovery to 16 million/mL on day 101 and 72 million/mL on day 170. All his samples showed sperm motility of 0%, although samples were previously frozen. In addition, 2 other participants had severe oligozoospermia (<5 million/mL) and 1 had mild oligozoospermia (<15 million/mL). Follow-up samples were available for 5 participants. Early sperm count recovery was observed in 3 participants, but 2 participants had a decrease in sperm count later in convalescence, and 1 participant had a count of 16 million/mL at 11 months (Table 1).

Figure 1

IgA, IgM, and IgG antibody responses against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike protein, receptor-binding domain (RBD), and nucleocapsid protein (NP) for participant 1 at days 72 and 78 from symptom onset. A) C0087 plasma SARS-CoV-2 spike-specific IgA; B) C0087 plasma SARS-CoV-2 spike-specific IgM; C) C0087 plasma SARS-CoV-2 spike-specific IgG; D) C0087 plasma SARS-CoV-2 spike/RBD‒specific IgA; E) C0087 plasma SARS-CoV-2 spike/RBD‒specific IgM; F) C0087 plasma SARS-CoV-2 spike/RBD‒specific IgG; G) C0087 plasma SARS-CoV-2 NP-specific IgA; H) C0087 plasma SARS-CoV-2 NP-specific IgM; I) C0087 plasma SARS-CoV-2 NP-specific IgG. OD450, optical density at 450 nm.

Figure 1. IgA, IgM, and IgG antibody responses against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike protein, receptor-binding domain (RBD), and nucleocapsid protein (NP) for participant 1 at days 72 and…

Figure 2

10, the response is considered positive. Peptide pool numbers indicate 17-mer overlapping peptides that encompass all 4 proteins. IFN, interferon; PBMCs, peripheral blood mononuclear cells. Error bars indicate mean ± SD.”>

Figure 2. T-cell binding domain responses against membrane, nucleocapsid, spike, and envelope proteins of severe acute respiratory syndrome coronavirus 2, as determined by human IFN-γ ELISpot assay. If the number of spots…

We assessed humoral and cell-mediated immune responses to evaluate level of immunity against SARS-CoV-2. We used immunoassays (11) to quantify IgM, IgG, and IgA binding (half of maximum effect) values against spike trimer and nucleocapsid protein (Figure 1). We performed antibody neutralization assays to measure the neutralization half-maximal inhibitory concentration (Figure 1; Appendix). Half of the maximum effect binding antibody responses and neutralization half-maximal inhibitory concentration against SARS-CoV-2 trimer were modest at days 72 and 78 (Table 2). We used a human interferon-γ ELISpot assay to determine the T-cell response against spike trimer, nucleocapsid, matrix, and envelope proteins at day 81 from symptom onset, which showed strong reactivity against matrix (Figure 2).


We report detection of SARS-CoV-2 RNA by qRT-PCR in semen and severe oligozoospermia in 1 patient 81 days after onset of severe COVID-19. Compared with reports that showed positive RT-PCR findings (79), we provide more granularity regarding clinical course, longitudinal assessment of sperm count, and host immune response.

Detection of SARS-CoV-2 RNA during the late convalescent phase might be attributed to COVID-19 severity, requiring mechanical ventilation and renal replacement therapy for the participant. This feature might have resulted in an enhanced systemic viremic state with subsequent seeding of accessory organs or the testes, an immune-privileged site, in the setting of generalized inflammation, and disruption of the blood–testis barrier (12). This possibility is supported by the participant having adequate humoral and cell-mediated immune responses and associated viral clearance of stool and saliva specimens surrounding the time when SARS-CoV-2 RNA was detected in semen.

In addition, 4 other study participants had oligozoospermia. Sperm count recovery was observed in 2 participants, but the other 2 did not provide longitudinal samples. Numerous reports have suggested a detrimental effect on semen quality after COVID-19 (9,13,14), hypothesized to occur secondary to viral illness and fever causing spermatogenic dysfunction (15). Given this transient insult, it is not unexpected that some of these men showed recovery.

One limitation of our study is that the initial semen sample was collected late in the convalescent phase, and the high Ct value probably indicates detection of inactive virus without risk for sexual transmission. However, if an acute-phase or early convalescent-phase specimen were collected, the Ct value might have been lower. Likewise, semen samples from the other 6 men were also limited to the late convalescence phase and mild acute COVID-19 illnesses, except for 1 participant who required mechanical ventilation, although his status was postvasectomy.

Given the small sample size, we cannot determine the contribution of other known etiologies of oligozoospermia, including obesity and oxygen therapy during hospitalization. In addition, we lacked preinfection semen analysis for comparison, and sperm motility would have been more accurately assessed if performed before freezing. Last, because of inherent difficulty in recruiting for serial semen collection, semen was only collected from a small proportion of participants enrolled in the cohort study. These findings are not generalizable to all male COVID-19 survivors and warrant further research.

In conclusion, SARS-CoV-2 RNA in semen appears to be an extremely rare event, but oligozoospermia has been reported more frequently. Risk factors for viral persistence in the male reproductive tract, longitudinal effects on semen quality, and viral transmission remain to be elucidated, but because of the large number of men in the convalescent phase worldwide, potential effects on reproductive health is not negligible.

Dr. Purpura is an instructor in medicine in the Department of Medicine, Division of Infectious Disease, Columbia University Irving Medical Center, New York, NY. His primary research interests include postinfectious sequelae and emerging pathogens.


The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors’ affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.

Continue Reading


NED-W vs BEL-W Live Score Dream11 Prediction Lineup FIH Women’s Pro League Netherlands Women vs Belgium Women




Another great and toughest battle between two groups of women will be taking place tonight. Yes, we are talking about FIH Women’s Pro League in which two powerful Hockey teams named Netherlands Women (NED-W) and Belgium Women (BEL-W). The match will be played by both teams on Wednesday, October 13. Now, it will be actually interesting to watch the full battle between both.

NED-W vs BEL-W Live Score

Here, you will get NED-W vs BEL-W Dream11 Prediction, Live Scores, Probable Lineups, and much more information that will help you to know the current statistics of both teams. We collect all the information from some reputed sources.

NED-W vs BEL-W Match Details

  • Match: Netherlands Women (NED-W) and Belgium Women (BEL-W), FIH Women’s Pro League
  • Venue: Wilrijkse Plein Stadium, Antwerp
  • Date and Time: Wednesday, 13th October 2021, 09:30 PM  IST

Now, both teams are deserved to win the upcoming match. Let us tell you that both teams will be going to play their first match in the league. Talking about Netherlands Women (NED-W) then all the players in this team are ready to make the entire environment highly anticipated. Many hockey fans are eagerly waiting to watch the full match between both teams.

On the flip side, Belgium Women (BEL-W) are also ready to make the entire battle very tough for the competitor. All the players are already very talented and experienced who give their best performance in the upcoming match. Belgium Women will be also going to play the first match in the ongoing league. Now, what will happen next will be worth watching. Both teams are considered to be the toughest contenders of the upcoming match.

NED-W vs BEL-W Probable Lineups

Netherlands Women: Sanne Koolen, Lidwej Wells, Xan de Waard, Laurien Leurink, Caia van Maasakker, Margot van Gaffen, Lreen van den Assem, Josine King, Anne Veenendaal, Kelly Jonker, and Lauren Tribe.

Belgium Women: Aisling D’Hooghe, Elena Sotgiu, Stephanie Vanden Borre, Joanne Peeters, Aline Fobe, Tiphaine Duquesne, Emma Puvrej, Link Hillewaert, Lucie Breyne, Michelle Struijk, and Barbara Nelen.

The winning probability of the Belgium Women (BEL-W) is more than Netherlands Women (NED-W). Now, it will be quite impressive to watch the toughest battle between both teams. Here, we will be providing NED-W vs BEL-W Live Scores that will help all Hockey fans to know the live scores during the battle. So, you just need to stay connected with us and refresh the page to get the updated result during the combat.

Source link

Continue Reading


Central Region Football Association up with Nyasa Capital Finance Cup’s draw – The Maravi Post




Nyasa Capital Finance Cup funds

By Edwin Mbewe

LILONGWE-(MaraviPost)-The draw for the inaugural MK5 million Nyasa Capital Finance regional Cup in the central regional on Wednesday, October 13, 2021 at Civo Stadium in the capital Lilongwe.

The cup is expected to kick off on October 23 till December 18, 2021.

The tournament will be participated by 24 Premier Division League teams which have been grouped into three zones,namely Mchinji, Salima and Lilongwe.

The top six teams from the Premier Division Log table will be seeded from first round of the cup.The 18 teams will play in a knock out format to determine the nine teams to join the seeded six.

Speaking to journalists after the draw,CRFA Vice Chairperson Goodall Chinjoka says the association is happy with the way the draw has been conducted.

Chinjoka therefore lauded Nyasa Capital Finance for the sponsorship rendered to their association saying it will help teams in the Central to be ever busy and improve the competition amongst them.

He however appealed to participating teams with supporter to avoid violence during the cup while selling the Nyasa Capital Finance products.

Kamuzu Barracks Reserve Team manager Alex Nkhwazi who represented other participants during the draw showed some satisfaction with the way the draw has been conducted.

Nkhwazi therefore appealed to participating teams to showcase beautiful football with a fair play so that the Sponsorship is safeguarded.

Football Association of Malawi (FAM) and Nyasa Capital Finance Limited Company signed a MK45 million Sponsorship for regional cups on September 17, 2021,which will run for three years and each region will be getting MK5 million per annum.

In Zone A, teams will meet as follows, Simbi FC vs LUANAR at Mchinji Community Ground,Kasungu Police vs St Gabriel at Kasungu Stadium while Chitedze Strikers will play Mchinji Boma Strikers at Civo/Nankhaka stadium.

Zone B,Ntcheu Strikers vs Ngolowindo at Dedza, Dwangwa United vs Kawinga at Nkhotakota Stadium and Kamuzu Barracks Reserve against Support Battalion at Civo/Nankhaka.

Zone C,Mtsiliza United vs Ascent Academy at Civo/Nankhaka, Dedza Young Soccer vs Mitundu Strikers while Mbabvi United will take on Ekas Freight Wanderers at Civo/Nankhaka.

The winner of this inaugural cup in the Central Region will take home MK1.2 million while the runners up will get MK500,000 with the third getting MK200,000.

NBS Bank Your Caring Bank

Continue Reading


Copyright © 2020 PRUMETRICS